Presentation is loading. Please wait.

Presentation is loading. Please wait.

The Scandinavian Sarcoma Group 25 Years´Jubilee Meeting St

Published byJonathan Lorentzen Modified over 5 years ago

Similar presentations

Presentation on theme: "The Scandinavian Sarcoma Group 25 Years´Jubilee Meeting St"— Presentation transcript:

1 The Scandinavian Sarcoma Group 25 Years´Jubilee Meeting St
The Scandinavian Sarcoma Group 25 Years´Jubilee Meeting St. Petersburg, May 4-7, 2004 THOR ALVEGARD

2

3 Sarcoma tumor board Patient Treatment plan Orthopaedic surgeon
Plastic Head & Neck Neuro Thorax Abdominal Cytologist Pathologist Cytogenetics X-ray diagnostician Patient Oncologist Treatment plan Surgery Radiotherapy: Preoperative Chemotherapy: Neoadjuvant Intraoperative Adjuvant Postoperative Intra-arterial Sequential Tumour necrosis factor a Brachytherapy isolated limb perfusion Hyperthermia Follow-up during and after treatment Centralized registration

4 Morphology (pathology and cytology)
Chairman L.G. Kindblom Gothenburg Coordinators J. Wejde Stockholm B. Bjerkehagen Oslo T. Böhling Helsinki H. Domanski Lund Tumor Biology Chairmen O. Myklebost Oslo F. Mertens Lund

5 SSG Register Chairman H. Bauer Stockholm Coordinators Ö. Berlin Gothenburg P. Gustafson Lund C. Trovik Bergen R. Huuhtanen Helsinki Epidemiology Chairman H. Olsson Lund

6 Diagnostic Radiology and
Nuclear Medicine Chairman I. Taksdal Oslo Coordinators V. Söderlund Stockholm M. Winderen Oslo

7 Surgery Chairman G. Follerås Oslo Coordinator O. Brosjö Stockholm Skeletal Metastasis Chairmen R. Wedin Stockholm J. Keller Aarhus

8 Chemotherapy Chairman S. Smeland Oslo Coordinator T. Wiebe Lund Clinical Pharmacology Chairman T. Skärby Lund Radiotherapy Chairman C. Blomqvist Helsinki Coordinators I. Turesson Uppsala Ø. Bruland Oslo

9 Theses planed MFH J. Engellau, 03 12 04, Lund
Leiomyosarcoma C. Svarvar, Helsinki Liposarcoma K. Engström, Gothenburg Chondrosarcoma B. Widhe, Stockholm Quality of life L. H. Aksnes, Oslo Skeletal metastases B. H. Hansen, Århus

10 Soft Tissue Sarcoma SSG I Adjuvant chemotherapy in STS 1981 – 86
SSG V Treatment program for STS – SSG X Treatment of metastatic STS (VIG) 1991 – 97 SSG XII Metastasecetomy and CHT for lungmet – 97 from STS. An EORTC/SSG randomized phase III study SSG XIII Treatment protocol for adults with – high-risk STS in extremities and trunk wall May 2004

11 Osteosarcoma SSG II Combination therapy in OS 1982 – 1990
SSG VIII Therapy of OS 1990 – 1998 ISG/SSG I An Italian-Scandinavian treatment and – 2000 research protocol for high-grade osteosarcoma of the extremities ISG/SSG II Treatment of metastatic and pelvic – 2003 osteosarcoma SSG XIV A Scandinavian treatment research 2000 protocol for extemity localized high- grade osteosarcoma Euroboss I A European treatment protocol for bone sarcoma in patients older than 40 years Euramos I An American/European treatment protocol for OS in patients <40 years May 2004

12 Ewing´s sarcoma SSG IV Combined modality therapy in EWS 1984 – 90
SSG IX Therapy of EWS 1990 – 99 ISG/SSG III ISG/SSG treatment protocol for non-metastatic EWS ISG/SSG IV ISG/SSG treatment protocol for 1999 high-risk EWS May 2004

13 Newly initiated SSG protocols
SSG XVI Centralized registration of patients with surgically treated skeletal metastases Recommendations for the Diagnosis and 2002 Treatment of Intraabdominal and Retroperitoneal Sarcomas SSG XVIII GIST (Adjuvant treatment) 2004 Euramos I 2004 Recommendations for the treatment of metastatic STS May 2004

14 Translational Sarcoma Research
Future directions Cancer Registries Biobanks Translational Sarcoma Research

15 Photo: Eva Henriksson

Download ppt "The Scandinavian Sarcoma Group 25 Years´Jubilee Meeting St"

Similar presentations

Radiologic Imaging Defines the local extent of a tumor Can be used to stage malignant disease Aids in the diagnosis Monitoring tumor changes after treatment.

Radiologic Imaging Defines the local extent of a tumor Can be used to stage malignant disease Aids in the diagnosis Monitoring tumor changes after treatment.
Neoadjuvant Chemotherapy in Malignant Peripheral Nerve Sheath Tumors Elizabeth Shurell, M.D., M.Phil. UCLA General Surgery Resident Research Fellow, Division.

Neoadjuvant Chemotherapy in Malignant Peripheral Nerve Sheath Tumors Elizabeth Shurell, M.D., M.Phil. UCLA General Surgery Resident Research Fellow, Division.
« A Clear cell sarcoma » 2007-11383 FN. 25 year-old male January 2007 3cm mass on the medial side of the right heel Early August 2007 3 cm clinical right.

« A Clear cell sarcoma » FN. 25 year-old male January cm mass on the medial side of the right heel Early August cm clinical right.
Swedish Childhood Cancer RegistryNB-CNS meeting 18/9 2008 The Swedish Childhood Cancer Registry  Göran Gustafsson, Mats Heyman, Åsa Vernby, Anders Larsson,

Swedish Childhood Cancer RegistryNB-CNS meeting 18/ The Swedish Childhood Cancer Registry  Göran Gustafsson, Mats Heyman, Åsa Vernby, Anders Larsson,
Gaurav Agarwal / Jul 2008 SGPGIMS, Lucknow, India Why is SGPGIMS Lucknow an ideal Hospital for state-of-the-art treatment of Breast Cancer.

Gaurav Agarwal / Jul 2008 SGPGIMS, Lucknow, India Why is SGPGIMS Lucknow an ideal Hospital for state-of-the-art treatment of Breast Cancer.
Janet Eary 1, Janet O'Sullivan 3, Finbarr O'Sullivan 3, E. U. Conrad 2 1. Nuclear Medicine/Radiology, University of Washington, Seattle, WA, United States.

Janet Eary 1, Janet O'Sullivan 3, Finbarr O'Sullivan 3, E. U. Conrad 2 1. Nuclear Medicine/Radiology, University of Washington, Seattle, WA, United States.
62 years old man Main complaint: Back pain at night but not during the day Loss of appettite Weight loss.

62 years old man Main complaint: Back pain at night but not during the day Loss of appettite Weight loss.
Synovial sarcoma- which patients don’t need adjuvant treatment? Khan M, Rankin KS, Beckingsale TB, Todd R, Gerrand CH North of England Bone and Soft Tissue.

Synovial sarcoma- which patients don’t need adjuvant treatment? Khan M, Rankin KS, Beckingsale TB, Todd R, Gerrand CH North of England Bone and Soft Tissue.
Silent but deadly – how to spot a sarcoma

Silent but deadly – how to spot a sarcoma
Neoadjuvant Adjuvant Curative Palliative Neoadjuvant Radiation therapy the results of a phase III study from Beijing demonstrated a survival benefit.

Neoadjuvant Adjuvant Curative Palliative Neoadjuvant Radiation therapy the results of a phase III study from Beijing demonstrated a survival benefit.
Soft Tissue Sarcomas August 15, 2015. Introduction Rare: only 8300 new cases annually in U.S. 3900 die annually from STS Mesodermal origin.

Soft Tissue Sarcomas August 15, Introduction Rare: only 8300 new cases annually in U.S die annually from STS Mesodermal origin.
PREOPERATIVE HYPOFRACTIONED RADIOTHERAPY IN LOCALIZED EXTREMITY/TRUNK WALL SOFT TISSUE SARCOMAS EARLY STUDY RESULTS Hanna Kosela; Milena Kolodziejczyk;

PREOPERATIVE HYPOFRACTIONED RADIOTHERAPY IN LOCALIZED EXTREMITY/TRUNK WALL SOFT TISSUE SARCOMAS EARLY STUDY RESULTS Hanna Kosela; Milena Kolodziejczyk;
BONE CANCER RAED ISSOU.

BONE CANCER RAED ISSOU.
Colorectal Cancer Center Jena 18.05.2011 Introduction In Germany, there are currently approximately 70 000 newly diagnosed patients with colorectal carcinoma.

Colorectal Cancer Center Jena Introduction In Germany, there are currently approximately newly diagnosed patients with colorectal carcinoma.
Piya Kiatisevi 1, Torsten Nielsen 2, Malcolm Hayes 2, Peter L Munk 3, Amy E LaFrance 4, Paul W Clarkson 4, Bassam A Masri 4 1 Orthopaedic Oncology Lerdsin.

Piya Kiatisevi 1, Torsten Nielsen 2, Malcolm Hayes 2, Peter L Munk 3, Amy E LaFrance 4, Paul W Clarkson 4, Bassam A Masri 4 1 Orthopaedic Oncology Lerdsin.
Challenges in the Treating of Bone and Soft Tissue Sarcomas Margaret von Mehren, MD Director Sarcoma Oncology Fox Chase Cancer Center Philadelphia, PA.

Challenges in the Treating of Bone and Soft Tissue Sarcomas Margaret von Mehren, MD Director Sarcoma Oncology Fox Chase Cancer Center Philadelphia, PA.
Incidence of Childhood Cancer. What is cancer ? Uncontrolled growth of cells Are these cancer cells abnormal? No, but their behaviour is.

Incidence of Childhood Cancer. What is cancer ? Uncontrolled growth of cells Are these cancer cells abnormal? No, but their behaviour is.
SPINDLE CELL SARCOMA OF BONE AN ASSESSMENT OF OUTCOME

SPINDLE CELL SARCOMA OF BONE AN ASSESSMENT OF OUTCOME
CLINICAL PRACTICE GUIDELINES Connective Tissue Oncology Society 2005 Meeting, Boca Raton Vivien Bramwell Chair, NCIC-CTG Sarcoma Committee Canadian Sarcoma.

CLINICAL PRACTICE GUIDELINES Connective Tissue Oncology Society 2005 Meeting, Boca Raton Vivien Bramwell Chair, NCIC-CTG Sarcoma Committee Canadian Sarcoma.
Chondrosarcoma of the chest wall: primary diagnostics is decisive for outcome Björn Widhe and Henrik Bauer.

Chondrosarcoma of the chest wall: primary diagnostics is decisive for outcome Björn Widhe and Henrik Bauer.

Similar presentations

Ads by Google